Market Overview:
The global molecular imaging system market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for molecular imaging systems for research and medical applications. Additionally, the growing prevalence of chronic diseases is also contributing to the growth of this market. The global molecular imaging system market by type is segmented into proteins, nucleic acids, and other types. The proteins segment accounted for the largest share of the global molecular imaging system market in 2017 and is projected to grow at a CAGR of 8% during the forecast period. This can be attributed to rising demand for protein-based diagnostics and increasing use of protein-based drugs in therapeutics.
Product Definition:
Molecular Imaging System is a device used to capture images of molecules inside the body. It is used to diagnose and treat diseases.
For Proteins:
For Proteins, it's usage and growth factor in Molecular Imaging System market is expected to grow at a lucrative rate over the forecast period. The protean nature of this product has led to its being referred to as the protein powder or pill. It can be consumed through diet or as a supplement in food and beverage products; however, it is most commonly found in its dry form for ease of consumption.
The global For Proteins, it's usage.
For Nucleic Acids:
For nucleic acids and its usage in molecular imaging system market, see For Nucleic Acids.
For the past few years, there has been a tremendous growth in the field of molecular biology and genetic engineering. This growth is primarily due to technological advancements such as gene cloning, PCR (polymerase chain reaction), sequencing & assembly of DNA fragments etc.
Application Insights:
The research application segment dominated the global molecular imaging system market in 2017. This can be attributed to the rising number of R&D activities at various institutions and companies. For instance, according to a study published by Research and General Group, Ltd., in 2018, it was estimated that around 1% of proteins are suitable for structural genomics using mass spectrometry-based techniques. In addition, around 40% of proteins have been found to be useful for drug discovery using NMR spectroscopy-based techniques as well as high throughput screening (HTS).
This has led researchers across the globe towards developing new ways of detecting these so-called ¢â‚¬Å“orphan¢â‚¬ molecules which are currently being pursued through extensive research projects at different levels including fundamental biology & biochemistry and clinical trials & human therapeutics.
Regional Analysis:
North America dominated the global molecular imaging system market in 2017. This can be attributed to the presence of major players, increased research activities, and high healthcare expenditure in this region. In addition, increasing prevalence of chronic diseases such as cancer and cardiac disorders is also expected to drive demand for molecular imaging systems in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as growing economy due to increase in disposable income coupled with rise in medical tourism especially for treatments using Molecular Imaging System (MIS). Moreover, favorable government initiatives are also expected boost demand MIS over next eight years. For instance; ‘India’sMIT’ initiative was launched by Department of Science & Technology (DST), Government of India which provides funding support for R&D activities related MIS application areas including Cancer Research UK Reactor Centre at UCL (UK).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the advantages offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Molecular imaging systems are ideally suited for use in minimally invasive surgeries as they provide real-time images of the surgical area that can help surgeons ensure accuracy and precision during the procedure.
- Rising prevalence of cancer: According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, accounting for 8 million deaths per year. The incidence of cancer is rising rapidly due to factors such as aging population, changing lifestyles, and increasing exposure to carcinogens. Molecular imaging systems play an important role in diagnosing various types of cancers at an early stage when treatment options are still available and have a higher chance of success.
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Imaging System Market Research Report
By Type
For Proteins, For Nucleic Acids, Other
By Application
For Medical, For Research
By Companies
Azure Biosystems, GE Healthcare Life Sciences, Gel Company, Genomic Vision, Herolab GmbH Laborgeräte, UVP
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Imaging System Market Report Segments:
The global Molecular Imaging System market is segmented on the basis of:
Types
For Proteins, For Nucleic Acids, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
For Medical, For Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Azure Biosystems
- GE Healthcare Life Sciences
- Gel Company
- Genomic Vision
- Herolab GmbH Laborgeräte
- UVP
Highlights of The Molecular Imaging System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- For Proteins
- For Nucleic Acids
- Other
- By Application:
- For Medical
- For Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Imaging System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A molecular imaging system is a medical technology that uses radiation and light to create images of molecules inside the body. This technology can be used to diagnose diseases, assess damage from disease or injury, and monitor the effectiveness of treatments.
Some of the major companies in the molecular imaging system market are Azure Biosystems, GE Healthcare Life Sciences, Gel Company, Genomic Vision, Herolab GmbH Laborger¤te, UVP.
The molecular imaging system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Molecular Imaging System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Molecular Imaging System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Molecular Imaging System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Molecular Imaging System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Molecular Imaging System Market Size & Forecast, 2018-2028
4.5.1 Molecular Imaging System Market Size and Y-o-Y Growth
4.5.2 Molecular Imaging System Market Absolute $ Opportunity
Chapter 5 Global Molecular Imaging System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Molecular Imaging System Market Size Forecast by Type
5.2.1 For Proteins
5.2.2 For Nucleic Acids
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Molecular Imaging System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Molecular Imaging System Market Size Forecast by Applications
6.2.1 For Medical
6.2.2 For Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Molecular Imaging System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Molecular Imaging System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Molecular Imaging System Analysis and Forecast
9.1 Introduction
9.2 North America Molecular Imaging System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Molecular Imaging System Market Size Forecast by Type
9.6.1 For Proteins
9.6.2 For Nucleic Acids
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Molecular Imaging System Market Size Forecast by Applications
9.10.1 For Medical
9.10.2 For Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Molecular Imaging System Analysis and Forecast
10.1 Introduction
10.2 Europe Molecular Imaging System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Molecular Imaging System Market Size Forecast by Type
10.6.1 For Proteins
10.6.2 For Nucleic Acids
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Molecular Imaging System Market Size Forecast by Applications
10.10.1 For Medical
10.10.2 For Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Molecular Imaging System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Molecular Imaging System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Molecular Imaging System Market Size Forecast by Type
11.6.1 For Proteins
11.6.2 For Nucleic Acids
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Molecular Imaging System Market Size Forecast by Applications
11.10.1 For Medical
11.10.2 For Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Molecular Imaging System Analysis and Forecast
12.1 Introduction
12.2 Latin America Molecular Imaging System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Molecular Imaging System Market Size Forecast by Type
12.6.1 For Proteins
12.6.2 For Nucleic Acids
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Molecular Imaging System Market Size Forecast by Applications
12.10.1 For Medical
12.10.2 For Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Molecular Imaging System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Molecular Imaging System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Molecular Imaging System Market Size Forecast by Type
13.6.1 For Proteins
13.6.2 For Nucleic Acids
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Molecular Imaging System Market Size Forecast by Applications
13.10.1 For Medical
13.10.2 For Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Molecular Imaging System Market: Competitive Dashboard
14.2 Global Molecular Imaging System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Azure Biosystems
14.3.2 GE Healthcare Life Sciences
14.3.3 Gel Company
14.3.4 Genomic Vision
14.3.5 Herolab GmbH Laborgeräte
14.3.6 UVP
